Logo-ijhpm
Int J Health Policy Manag. 2023;12: 7292 | Published on: 2023 Jun 06. doi: 10.34172/ijhpm.2023.7292
PMID: 37579378        PMCID: PMC10462073

Original Article

Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy

Selda Ulucanlar 1 ORCID, Kathrin Lauber 2 ORCID, Alice Fabbri 1 ORCID, Ben Hawkins 3 ORCID, Melissa Mialon 4 ORCID, Linda Hancock 5 ORCID, Viroj Tangcharoensathien 6 ORCID, Anna B. Gilmore 1 * ORCID

Cited by CrossRef:

1- Evans-Reeves K, Matthes B, Chamberlain P, Paichadze N, Gilmore A, Mialon M. Intimidation against advocates and researchers in the tobacco, alcohol and ultra-processed food spaces: a review. 2024;39(6) [Crossref]
2- van Schalkwyk M, Hawkins B, Cassidy R, Collin J, Gilmore A, Petticrew M. Learning from tobacco control to tackle gambling industry harms. BMJ. 2025;:e082866 [Crossref]
3- van Schalkwyk M, Hawkins B, Petticrew M, Maani N, Garde A, Reeves A, McKee M. Agnogenic practices and corporate political strategy: the legitimation of UK gambling industry-funded youth education programmes. 2024;39(1) [Crossref]
4- van den Akker A, Gilmore A, Fabbri A, Knai C, Rutter H. Aligning rhetoric with reality: a qualitative analysis of multistakeholder initiatives in the global food system. 2024;39(6) [Crossref]
5- Brook A, Körner K, van Schalkwyk M, Barnes A, Petticrew M. Overcoming doubt: developing CDoH Essentials, a practical tool to introduce the commercial determinants of health. 2024;39(6) [Crossref]
6- Davidson S, Lock I. Argumentation strategies in lobbying: the discursive struggle over proposals to regulate Big Tech. JCOM. 2024; [Crossref]
7- Matthes B, Alebshehy R, Gilmore A. “They try to suppress us, but we should be louder”: a qualitative exploration of intimidation in tobacco control. Global Health. 2023;19(1) [Crossref]
8- Gilmore A, van den Akker A. Protecting future generations from commercially driven health harms: lessons from tobacco control. The Lancet. 2024;404(10449):221 [Crossref]
9- Burgess R, Nyhan K, Freudenberg N, Ransome Y. Corporate activities that influence population health: a scoping review and qualitative synthesis to develop the HEALTH-CORP typology. Global Health. 2024;20(1) [Crossref]
10- Rychert M, Sultan A, Mialon M. Editorial: AI and new digital technologies have transformed alcohol and other drug industries lobbying. DHS. 2024;25(1):1 [Crossref]
11- Barry R. Challenges achieving horizontal coherence across health and public security policies in formulating Uruguay’s cannabis regulation. 2024;39(5) [Crossref]
12- Gilmore A, Alebshehy R, Bialous S. How Could We Establish Monitoring and Surveillance of Health-Harming Corporations and Can Governments Be Trusted to Do It? Comment on "National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis". Int J Health Policy Manag. 2024;13:8621 [Crossref]
13- McCarthy S, Pitt H, Randle M, Arnot G, Marko S, Daube M, Thomas S. Community sports leaders’ perceptions of the risks and benefits of gambling sponsorship in community sport. 2024;39(6) [Crossref]
14- Anderson R, Jones M, Jongenelis M. Industry actor communication practices in submissions on electronic nicotine delivery system policy in Australia. Tob Control. 2025;:tc-2024-059013 [Crossref]
15- Fialon M, Nabec L, Julia C. Understanding the influence of stakeholders on the implementation of front-of-pack nutrition labelling in the absence of public debate: the case of Portugal. Health Res Policy Sys. 2024;22(1) [Crossref]
16- van Schalkwyk M, Maani N, Hawkins B, Petticrew M, Buse K. Reclaiming the narrative: countering harmful commercial discourses. 2024;39(6) [Crossref]
17- Gupta A. Why there is a Need to Priortise Regulation of Ultra-processed Foods and HFSS Foods in India?. 2024; [Crossref]
18- Foster H, Mair F, O'Donnell C. Exploring Public, Practitioner and Policymaker Perspectives of Unhealthy Lifestyle Factors in the Context of Socioeconomic Deprivation: A Qualitative Study. Health Expectations. 2024;27(5) [Crossref]
19- Maani N, van Schalkwyk M, Wiseman A, Petticrew M. Commercially driven efforts to frame alcohol harms have no place in UK health policy development. BMJ. 2024;:q800 [Crossref]
20- Lacy-Nichols J, Baradar H, Crosbie E, Cullerton K. Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures. Int J Health Policy Manag. 2024;13:8497 [Crossref]
21- Hartwell G, Gilmore A, van Schalkwyk M, McKee M. Sunak’s smoke-free generation: spare a thought for the tobacco industry. BMJ. 2023;:p2922 [Crossref]
22- Schölin L, Petticrew M, Collin J, Knipe D, Barry R, Eddleston M, Gunnell D, Pearson M, van Schalkwyk M. Mapping commercial practices of the pesticide industry to shape science and policymaking: a scoping review. 2025;40(1) [Crossref]
23- Pulido Valente F, Baptista A, Vieira B. Analysis of the Alcohol Industry’s Corporate Social Responsibility Practices in Portugal. Port J Public Health. 2024;:1 [Crossref]
24- Walls H, McKee M, Balabanova D. The need to call out corporate corruption in health. The Lancet. 2025; [Crossref]
25- Madden M, Bartlett A, McCambridge J. Constructing public–private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking. Global Health. 2023;19(1) [Crossref]
26- Droog N, Dijkstra C, van Selm N, Poelman M, Mackenbach J. Unveiling viewpoints on national food environment policies in the Dutch newspaper discourse: an interpretative media content analysis. Int J Behav Nutr Phys Act. 2024;21(1) [Crossref]
27- Matthes B, Legg T, Hiscock R, Gallagher A, Silver K, Alaouie H, Thomas D, Gilmore A. The UK Tobacco and Vapes Bill (2023/4): framing strategies used by tobacco and nicotine industry actors faced with an endgame policy (a generational sales ban of tobacco products) and nicotine product restrictions. Tob Control. 2025;:tc-2024-059207 [Crossref]
28- Hamel V, Mialon M, Moubarac J. ‘The company is using the credibility of our profession’: exploring experiences and perspectives of registered dietitians from Canada about their interactions with commercial actors using semi-structured interviews. Public Health Nutr. 2024;27(1) [Crossref]
29- Shaw C, Randal E, Macmillan A, Tripp D, Miller A, Woodward A, Thu W. Improving health and preventing cancer through a better transport system in Aotearoa/New Zealand. Journal of the Royal Society of New Zealand. 2024;:1 [Crossref]
30- van den Akker A, Fabbri A, Bertscher A, Gilmore A, Knai C, Cavill N, Rutter H. Industry influence on public health policy formulation in the UK: a complex systems approach. 2024;39(6) [Crossref]
31- Zatoński M, Bertscher A, Gallagher A, Matthes B. Unpacking complexities surrounding tobacco control policy formulation and tobacco industry interference in South Africa: a qualitative study. 2025; [Crossref]
32- Thomas S, Cowlishaw S, Francis J, van Schalkwyk M, Daube M, Pitt H, McCarthy S, McGee D, Petticrew M, Rwafa-Ponela T, Minja A, Fell G. Global public health action is needed to counter the commercial gambling industry. 2023;38(5) [Crossref]